Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the impact of a brief motivational intervention BMI delivered by pharmacists on reducing the use of benzodiazepines and related drugs BZDZ in adults who have been using these medications long term. The study aims to compare this intervention against usual pharmacy dispensing practices, focusing on reducing daily drug doses and monitoring clinical symptoms related to anxiety and sleep disorders. The research addresses concerns about the widespread long-term use of BZDZ and the need for practical deprescribing strategies in primary care. Participants will be randomly assigned to either receive the BMI, which involves identifying patients and using motivational techniques to encourage dose reduction, or to continue with standard pharmacy care without this intervention. The intervention targets adults with at least six months of continuous BZDZ use. The study will evaluate effects at 6 and 12 months, with repeated assessments of drug dose, cessation rates, clinical symptoms, misuse, and adverse events. During the study, participants will complete questionnaires and undergo clinical evaluations to measure anxiety, depression, insomnia severity, and any clinical worsening. Data on drug misuse and transfers to other addictive behaviors will also be collected. Safety will be monitored through adverse event reporting at multiple time points up to 12 months. Overall, the study spans at least 12 months to assess both short- and longer-term outcomes of the intervention.